AtriCure (NASDAQ:ATRC) Price Target Raised to $50.00
AtriCure (NASDAQ:ATRC – Free Report) had its target price upped by Piper Sandler from $40.00 to $50.00 in a research report report published on Thursday,Benzinga reports. They currently have an overweight rating on the medical device company’s stock. Other equities research analysts have also recently issued research reports about the company. Needham & Company LLC […]
AtriCure (NASDAQ:ATRC – Free Report) had its target price upped by Piper Sandler from $40.00 to $50.00 in a research report report published on Thursday,Benzinga reports. They currently have an overweight rating on the medical device company’s stock. Other equities research analysts have also recently issued research reports about the company. Needham & Company LLC […]
